Rosumeck, N.; Timmermann, L.; Klein, F.; Bahra, M.; Stintzig, S.; Malinka, T.; Pelzer, U.
Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection? Medicina 2021, 57, 77.
https://doi.org/10.3390/medicina57010077
AMA Style
Rosumeck N, Timmermann L, Klein F, Bahra M, Stintzig S, Malinka T, Pelzer U.
Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection? Medicina. 2021; 57(1):77.
https://doi.org/10.3390/medicina57010077
Chicago/Turabian Style
Rosumeck, Nathalie, Lea Timmermann, Fritz Klein, Marcus Bahra, Sebastian Stintzig, Thomas Malinka, and Uwe Pelzer.
2021. "Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?" Medicina 57, no. 1: 77.
https://doi.org/10.3390/medicina57010077
APA Style
Rosumeck, N., Timmermann, L., Klein, F., Bahra, M., Stintzig, S., Malinka, T., & Pelzer, U.
(2021). Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection? Medicina, 57(1), 77.
https://doi.org/10.3390/medicina57010077